Note: Wholesale acquisition costs from the Connecticut WAC disclosure form dated November 9, 2026, which the Entyvio HCP site links in its page footer. Each price is for the package size listed beside it. The disclosure lists no price for the prefilled syringe (NDC 64764-107-11).
Note: Program terms as captured from the Entyvio HCP patient support page on November 13, 2026; Takeda states it may change or end the program at any time. The maximum is $9,000 per calendar year when a health plan uses a copay maximizer program (see the copay maximizer question).
Does the Entyvio copay program work with copay maximizer or accumulator plans?
Note: Program terms as captured from the Entyvio HCP patient support page on November 13, 2026. The program is for eligible commercially insured patients only; government-insured patients are excluded.
Can Medicare patients use Entyvio copay assistance or patient assistance?
Note: The second passage is an eligibility condition, and the third a patient declaration, of the ENTYVIO Patient Assistance Program application in the EntyvioConnect enrollment form, which applies to patients approved for that program (see the patient assistance question). Terms as captured November 13, 2026.
Note: Manufacturer statement based on Managed Markets Insight & Technology data as of December 2025, as captured November 13, 2026. For the Entyvio Pen, the manufacturer's covered-lives figure includes plans that require biologic step edits. The page gives no share of covered lives and no figure for Medicare or Medicaid.
Note: Terms from the EntyvioConnect Terms and Conditions document (US-VED-4379v1.0, dated 06/26), linked from the Entyvio HCP home page, as captured November 13, 2026. The patient support page describes the program as covering insurance delays; the Terms and Conditions require a coverage exclusion, coverage denial, or prior authorization denial.
Does Entyvio have a bridge program for gaps in insurance coverage?
Note: Terms from the EntyvioConnect Terms and Conditions document (US-VED-4379v1.0, dated 06/26), linked from the Entyvio HCP home page, as captured November 13, 2026.
Which specialty pharmacies carry the Entyvio Pen?
Applies to Moderately to severely active ulcerative colitis in adults, subcutaneous maintenance after two intravenous induction doses
Note: From the Specialty Pharmacy Information sheet (US-VED-2383v6.0, dated 05/26) linked from the Entyvio Pen dosing page, as captured November 13, 2026.
Prior authorization
How does prior authorization work for Entyvio and the Entyvio Pen?